Tag: sugemalimab

Stock

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III Non-Small Cell Lung Cancer

23/03/2025
admin

CStone Submits Application to the European Medicines Agency for New Indication of Sugemalimab in Stage III…

Stock

CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO Guideline

09/02/2025
admin

CStone Announces Inclusion of Cejemly ® (sugemalimab) as a First-Line Combination Therapy for NSCLC in ESMO…